JDD August Highlights – Special Focus: Psoriasis
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis. Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study   READ NOW The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps …
Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit
basal cell carcinomaINTRODUCTION Periocular basal cell carcinoma (BCC) is the most common eyelid malignancy concomitant with ocular morbidity and quality of life impact.1,2 Orbital invasion occurs in 2% of cases and poses challenges for management.1,3 JDD authors highlight a multidisciplinary approach to the treatment of advanced periocular BCC.   CASE JDD authors discuss a 56-year-old male who presente …
basal cell carcinoma
Mohs Micrographic Surgery in Skin of Color
Mohs Micrographic SurgeryAt the 2023 Skin of Color Update, Dr. David Ciocon, Director of Dermatologic Surgery, Mohs Micrographic Surgery (MMS) and Procedural Dermatology at the Montefiore Medical Center, Albert Einstein College of Medicine, provided a comprehensive exploration of MMS in patients with skin of color, with a focus on defining keratinocyte carcinoma and shedding light on disparities within this patient popula …
Mohs Micrographic Surgery
Cosmeceuticals for Photodamage and Hyperpigmentation
CosmeceuticalsNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Diane S. Berson, associate professor of dermatology at Weill Cornell Medical College. Watch as Dr. Berson shares the cosmeceutical ingredients that dermatology clinicians can use synergistically to address photodamage and hyperpigmentation. Learn what ingredients are newly available and how cosmeceutica …
Cosmeceuticals
Pulling Back the Curtain on Clinical Trials & Diverse Patient Populations 
clinical trialsNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Dr. Alexis shares his take on how to address issues of mistrust that may impede clinical trial recruitment in diverse patient populations. Watch as he details why i …
clinical trials
error

Enjoy this blog? Please spread the word :)